Tumor cells treated with chemotherapy or radiotherapy can express “danger” and “eat-me” signals on the cell surface (e.g., NKG2D ligands, CRT) or can release immunostimulatory factors (e.g., HMGB1) to stimulate immune effectors (9). This evidence concerns the gene HMGB1 and neoplasm.